Abstract:Chromosome stability models are usually qualitative models derived from molecular-genetic mechanisms for DNA repair, DNA synthesis, and cell division. While qualitative models are informative, they are also challenging to reformulate as precise quantitative models. In this report we explore how (A) laboratory experiments, (B) quantitative simulation, and (C) seriation algorithms can inform models of chromosome stability. Laboratory experiments were used to identify 19 genes that when over-expressed cause chrom… Show more
“…In contrast, NSR1 deletion shows a positive genetic interaction with the RNA Pol II CTD-associated phosphatase, FCP1, which negatively regulates transcription (51). NSR1 overexpression also subtly increases chromosomal instability (52), which might result from premature Start activation (53). These interactions with transcriptional regulators are consistent with our proposed model for Nsr1 function in G1/S transcription activation.…”
Commitment to cell division at the end of G1 phase, termed Start in the budding yeast Saccharomyces cerevisiae, is strongly influenced by nutrient availability. To identify new dominant activators of Start that might operate under different nutrient conditions, we screened a genome-wide ORF overexpression library for genes that bypass a Start arrest caused by absence of the G1 cyclin Cln3 and the transcriptional activator Bck2. We recovered a hypothetical gene YLR053c, renamed NSR1 for Nitrogen-responsive Start Regulator 1, which encodes a poorly characterized 108 amino acid microprotein. Endogenous Nsr1 was nuclear-localized, restricted to poor nitrogen conditions, induced upon mTORC1 inhibition, and cell cycle-regulated with a peak at Start. NSR1 interacted genetically with SWI4 and SWI6, which encode the master G1/S transcription factor complex SBF. Correspondingly, Nsr1 physically interacted with Swi4 and Swi6and was localized to G1/S promoter DNA. Nsr1 exhibited inherent transactivation activity and fusion of Nsr1 to the SBF inhibitor Whi5 was sufficient to suppress other Start defects. Nsr1 appears to be a recently evolved microprotein that rewires the G1/S transcriptional machinery under poor nutrient conditions.
Author SummaryUnicellular microorganisms must adapt to ever-changing nutrient conditions and hence must adjust cell growth and proliferation to maximize fitness. In the budding yeast Saccharomyces cerevisiae, commitment to cell division, termed Start, is heavily influenced by nutrient availability. The mechanisms of Start activation under conditions of nutrient limitation are less well characterized than under nutrient excess. To identify potential new Start regulators specific to poor nutrient environments, we screened for genes able to bypass a genetic Start arrest caused by loss of the G1 cyclin Cln3 and the transcriptional activator Bck2. This screen uncovered YLR053c, which we renamed NSR1 for Nitrogen-responsive Start Regulator. Sequence analysis across yeast species indicated that Nsr1 is a recently-evolved microprotein. We showed that NSR1 is nutrient-and cell cycle-regulated, and directly binds the main G1/S transcription factor complex SBF. We demonstrated that Nsr1 has an intrinsic trans-activation activity and provided genetic evidence to suggest that Nsr1 can bypass the requirement for normal Cln3-dependent 3 activation of SBF. These results uncover a new mechanism of Start activation and demonstrate how microproteins can rapidly emerge to rewire fundamental cellular processes.
“…In contrast, NSR1 deletion shows a positive genetic interaction with the RNA Pol II CTD-associated phosphatase, FCP1, which negatively regulates transcription (51). NSR1 overexpression also subtly increases chromosomal instability (52), which might result from premature Start activation (53). These interactions with transcriptional regulators are consistent with our proposed model for Nsr1 function in G1/S transcription activation.…”
Commitment to cell division at the end of G1 phase, termed Start in the budding yeast Saccharomyces cerevisiae, is strongly influenced by nutrient availability. To identify new dominant activators of Start that might operate under different nutrient conditions, we screened a genome-wide ORF overexpression library for genes that bypass a Start arrest caused by absence of the G1 cyclin Cln3 and the transcriptional activator Bck2. We recovered a hypothetical gene YLR053c, renamed NSR1 for Nitrogen-responsive Start Regulator 1, which encodes a poorly characterized 108 amino acid microprotein. Endogenous Nsr1 was nuclear-localized, restricted to poor nitrogen conditions, induced upon mTORC1 inhibition, and cell cycle-regulated with a peak at Start. NSR1 interacted genetically with SWI4 and SWI6, which encode the master G1/S transcription factor complex SBF. Correspondingly, Nsr1 physically interacted with Swi4 and Swi6and was localized to G1/S promoter DNA. Nsr1 exhibited inherent transactivation activity and fusion of Nsr1 to the SBF inhibitor Whi5 was sufficient to suppress other Start defects. Nsr1 appears to be a recently evolved microprotein that rewires the G1/S transcriptional machinery under poor nutrient conditions.
Author SummaryUnicellular microorganisms must adapt to ever-changing nutrient conditions and hence must adjust cell growth and proliferation to maximize fitness. In the budding yeast Saccharomyces cerevisiae, commitment to cell division, termed Start, is heavily influenced by nutrient availability. The mechanisms of Start activation under conditions of nutrient limitation are less well characterized than under nutrient excess. To identify potential new Start regulators specific to poor nutrient environments, we screened for genes able to bypass a genetic Start arrest caused by loss of the G1 cyclin Cln3 and the transcriptional activator Bck2. This screen uncovered YLR053c, which we renamed NSR1 for Nitrogen-responsive Start Regulator. Sequence analysis across yeast species indicated that Nsr1 is a recently-evolved microprotein. We showed that NSR1 is nutrient-and cell cycle-regulated, and directly binds the main G1/S transcription factor complex SBF. We demonstrated that Nsr1 has an intrinsic trans-activation activity and provided genetic evidence to suggest that Nsr1 can bypass the requirement for normal Cln3-dependent 3 activation of SBF. These results uncover a new mechanism of Start activation and demonstrate how microproteins can rapidly emerge to rewire fundamental cellular processes.
“…In contrast, NRS1 deletion shows a positive genetic interaction with the RNA Pol II CTD-associated phosphatase, FCP1, which negatively regulates transcription [ 63 ]. NRS1 overexpression also subtly increases chromosomal instability [ 64 ], which might result from premature Start activation [ 65 ]. These interactions with transcriptional regulators are consistent with our proposed model for Nrs1 function in G1/S transcription activation.…”
Commitment to cell division at the end of G1 phase, termed Start in the budding yeast Saccharomyces cerevisiae, is strongly influenced by nutrient availability. To identify new dominant activators of Start that might operate under different nutrient conditions, we screened a genome-wide ORF overexpression library for genes that bypass a Start arrest caused by absence of the G1 cyclin Cln3 and the transcriptional activator Bck2. We recovered a hypothetical gene YLR053c, renamed NRS1 for Nitrogen-Responsive Start regulator 1, which encodes a poorly characterized 108 amino acid microprotein. Endogenous Nrs1 was nuclear-localized, restricted to poor nitrogen conditions, induced upon TORC1 inhibition, and cell cycle-regulated with a peak at Start. NRS1 interacted genetically with SWI4 and SWI6, which encode subunits of the main G1/S transcription factor complex SBF. Correspondingly, Nrs1 physically interacted with Swi4 and Swi6 and was localized to G1/S promoter DNA. Nrs1 exhibited inherent transactivation activity, and fusion of Nrs1 to the SBF inhibitor Whi5 was sufficient to suppress other Start defects. Nrs1 appears to be a recently evolved microprotein that rewires the G1/S transcriptional machinery under poor nitrogen conditions.
“…The simplicity and genetic tractability of the budding yeast, Saccharomyces cerevisiae, make it a model experimental system to delineate conserved biological pathways and processes such as those involved in CIN (Measday and Stirling 2016). Large-scale yeast screens have generated a comprehensive list of genes whose mutation (Myung et al 2001;Smith et al 2004;Kanellis et al 2007;Yuen et al 2007;Andersen et al 2008;Stirling et al 2011) or overexpression (Zhu et al 2015;Ang et al 2016;Duffy et al 2016;Frumkin et al 2016;Tutaj et al 2019) contribute to CIN. Yeast can also be utilized to identify chemical sensitivities to cytotoxic agents caused by CIN gene mutations that may be exploited to selectively target tumor cells (O'Neil et al 2017).…”
Cross-species complementation can be used to generate humanized yeast, which is a valuable resource with which to model and study human biology. Humanized yeast can be used as an in vivo platform to screen for chemical inhibition of human protein drug targets. To this end, we report the systematic complementation of nonessential yeast genes implicated in chromosome instability (CIN) with their human homologs. We identified 20 human–yeast complementation pairs that are replaceable in 44 assays that test rescue of chemical sensitivity and/or CIN defects. We selected a human–yeast pair (hFEN1/yRAD27), which is frequently overexpressed in cancer and is an anticancer therapeutic target, to perform in vivo inhibitor assays using a humanized yeast cell-based platform. In agreement with published in vitro assays, we demonstrate that HU-based PTPD is a species-specific hFEN1 inhibitor. In contrast, another reported hFEN1 inhibitor, the arylstibonic acid derivative NSC-13755, was determined to have off-target effects resulting in a synthetic lethal phenotype with yRAD27-deficient strains. Our study expands the list of human–yeast complementation pairs to nonessential genes by defining novel cell-based assays that can be utilized as a broad resource to study human drug targets.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.